Abstract
Nanosized mesoporous iron–carboxylate [MIL-100(Fe)]-encapsulated Keggin phosphotungstic acid H3PW12O40 (PW) was fabricated via an environmentally friendly hydrothermal synthesis method and characterized by Fourier-transform infrared spectroscopy, high-resolution transmission electron microscopy, field-emission scanning electron microscopy, particle size analysis, and powder X-ray diffraction analysis. The metal content was analyzed by energy-dispersive X-ray spectroscopy. PW@MIL-100(Fe) was then studied as a drug delivery system, exhibiting the ability to entrap epirubicin (EPI) as a model drug. The drug loading efficiency, drug content, and drug release behavior of PW@MIL-100(Fe), MIL-100(Fe), and PW@HKUST-1 [where HKUST-1 is Cu3(BTC)2 with BTC = benzene-1,3,5-tricarboxylic acid] were also studied. The results indicate that PW@MIL-100(Fe) possessed high adsorption capacity (28 wt%) and loading efficiency (91.6 %) for epirubicin. Drug release from PW@MIL-100(Fe) at different pH values (5, 5.8, 6.5, and 7.4) and temperatures and with an alternative magnetic field was investigated, and the stability of the nanocarrier after EPI release was studied by Fourier-transform infrared spectroscopy and field-emission scanning electron microscopy. Cellular toxicity was also investigated. The results show that this is a good candidate as a future drug nanocarrier.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
